Cultivation Capital

VedaPointe, founded in 2019 and based in St. Louis, Missouri, specializes in health technology by providing strategic expertise, incubation assistance, and technical services for clinical and administrative healthcare data. The company operates a platform designed to enhance communication channels and support new healthcare economic models. Its data ecosystem facilitates the exchange of critical healthcare data required for value-based care within revenue cycle management. By enabling healthcare professionals to leverage integrated clinical and administrative data, VedaPointe aims to drive new value and improve overall healthcare outcomes.

Clever Real Estate is a company that specializes in the fields of commercial real estate and online marketplaces. It offers a software platform that guides its users through the process of interviewing real estate agents to find the right one for them. The company was founded in 2017 and is headquartered in St Louis, Missouri.

SimpleRose Inc. is a technology company based in Saint Louis, Missouri, that specializes in developing a prescriptive analytics platform aimed at enhancing decision-making processes in complex environments. Founded in 2018, the company's solutions focus on optimizing operations through applications such as scheduling, production planning, and portfolio optimization. By leveraging algorithmic innovations for improved numerical accuracy and speed, SimpleRose enables organizations to tackle intricate operational challenges and make informed decisions in real-time.

Mission Control GG, Inc. is a mobile application designed to facilitate recreational esports leagues for gamers, akin to local adult sports leagues. Established in 2018 and headquartered in Saint Louis, Missouri, the platform allows users to join leagues with friends or participate in those organized by local entities. Mission Control provides comprehensive league management solutions, including scheduling, score validation, and champion determination. It also serves as a forum for league members, enhancing community engagement. Organizations such as community groups, colleges, and LAN centers can utilize Mission Control to host various game titles, attract participants, and streamline their esports operations, fostering a vibrant gaming community.

iSite Media, LLC specializes in advertising and marketing services utilizing digital display technology. Founded in 2015 and based in St. Louis, Missouri, the company focuses on delivering brand promotion through digital display networks located in restrooms. This unique placement allows for high visibility and relevance, enhancing consumer recall and engagement. iSite Media bridges the gap between content and consumers, ensuring that advertisements reach the appropriate audience in various environments outside the home. In 2017, the company rebranded from its former name, Sitting Duck Advertising, to better reflect its innovative approach to media campaigns.

Geneoscopy, LLC, based in Saint Louis, Missouri, specializes in developing non-invasive diagnostic tests aimed at preventing, detecting, and guiding treatment for gastrointestinal diseases, particularly colorectal cancer. Founded in 2015, the company utilizes a proprietary platform that extracts stool-derived eukaryotic RNA (seRNA) to create a multi-target RNA biomarker panel. This innovative approach allows for the identification of colorectal cancer by capturing the effects of DNA mutations associated with the disease. Geneoscopy's technology not only enhances screening compliance but also facilitates the early detection of colorectal neoplasms, ultimately aiming to reduce morbidity and mortality linked to colorectal cancer. The company is also exploring additional applications of its technology for related gastrointestinal conditions.

Clever Real Estate is a company that specializes in the fields of commercial real estate and online marketplaces. It offers a software platform that guides its users through the process of interviewing real estate agents to find the right one for them. The company was founded in 2017 and is headquartered in St Louis, Missouri.

Balto Software Inc. is a developer of sales software that leverages artificial intelligence and real-time conversation analytics to enhance the performance of sales representatives during phone calls. Founded in 2017 and based in Saint Louis, Missouri, Balto's platform offers agents live guidance by alerting them to mistakes and providing suggestions tailored to specific products, phrases, and industry terminology. The software monitors conversations for compliance and quality, allowing representatives to self-correct in real time, while also equipping managers with tools to oversee key behaviors. Balto's solutions support various functions, including sales leadership, customer service, and compliance, and have guided over 150 million calls, resulting in substantial revenue increases and high customer ratings. The company is trusted by numerous contact centers, helping to prevent missed sales opportunities and improve customer experiences.

SentiAR, Inc. is a digital health company based in St. Louis, Missouri, specializing in 3D augmented reality solutions for interventional medical procedures. Founded in 2017 as a spin-off from Washington University, SentiAR has developed a platform that offers real-time holographic visualization of patients' anatomical structures and catheter locations. This technology integrates data from CT, MRI, and real-time mapping systems to create a controllable 3D holographic interface. The platform aims to enhance the delivery of care by allowing clinicians to visualize complex cardiac anatomy directly over the patient, thereby improving the treatment of cardiac arrhythmias during catheterization procedures. SentiAR is in the process of preparing its platform for submission to the FDA.

iSite Media, LLC specializes in advertising and marketing services utilizing digital display technology. Founded in 2015 and based in St. Louis, Missouri, the company focuses on delivering brand promotion through digital display networks located in restrooms. This unique placement allows for high visibility and relevance, enhancing consumer recall and engagement. iSite Media bridges the gap between content and consumers, ensuring that advertisements reach the appropriate audience in various environments outside the home. In 2017, the company rebranded from its former name, Sitting Duck Advertising, to better reflect its innovative approach to media campaigns.

Textel CX Inc., established in 2014 and headquartered in Saint Louis, Missouri, specializes in developing a cloud-based texting platform for contact centers and businesses. Its primary product, Textel, enables these entities to engage with customers via text, enhancing customer experience and increasing engagement. Key features include landline texting, API integrations, and a text-to-find service, catering to industries such as car dealerships, insurance, healthcare, and retail. Textel serves nearly 800 customers across North America, facilitating inbound/outbound SMS and MMS texts, and integrating with leading systems of record.

FinLocker, LLC is a financial technology company founded in 2014 and based in St. Louis, Missouri. It develops a consumer-enabled financial data platform that facilitates the loan process for mortgages and other financial products. The platform serves both businesses and consumers by streamlining loan transactions and enhancing the overall financial experience. For businesses, FinLocker provides tools that cut costs, reduce fraud, and mitigate risks while improving customer satisfaction and operational efficiency. For consumers, the platform simplifies the loan application process, minimizes paperwork, and enables better management of personal finances. Using consumer consent, FinLocker captures essential borrower data and employs intelligent analytics to offer tailored loan product recommendations based on individual financial profiles.

Balto Software Inc. is a developer of sales software that leverages artificial intelligence and real-time conversation analytics to enhance the performance of sales representatives during phone calls. Founded in 2017 and based in Saint Louis, Missouri, Balto's platform offers agents live guidance by alerting them to mistakes and providing suggestions tailored to specific products, phrases, and industry terminology. The software monitors conversations for compliance and quality, allowing representatives to self-correct in real time, while also equipping managers with tools to oversee key behaviors. Balto's solutions support various functions, including sales leadership, customer service, and compliance, and have guided over 150 million calls, resulting in substantial revenue increases and high customer ratings. The company is trusted by numerous contact centers, helping to prevent missed sales opportunities and improve customer experiences.

Mission Control GG, Inc. is a mobile application designed to facilitate recreational esports leagues for gamers, akin to local adult sports leagues. Established in 2018 and headquartered in Saint Louis, Missouri, the platform allows users to join leagues with friends or participate in those organized by local entities. Mission Control provides comprehensive league management solutions, including scheduling, score validation, and champion determination. It also serves as a forum for league members, enhancing community engagement. Organizations such as community groups, colleges, and LAN centers can utilize Mission Control to host various game titles, attract participants, and streamline their esports operations, fostering a vibrant gaming community.

iSite Media, LLC specializes in advertising and marketing services utilizing digital display technology. Founded in 2015 and based in St. Louis, Missouri, the company focuses on delivering brand promotion through digital display networks located in restrooms. This unique placement allows for high visibility and relevance, enhancing consumer recall and engagement. iSite Media bridges the gap between content and consumers, ensuring that advertisements reach the appropriate audience in various environments outside the home. In 2017, the company rebranded from its former name, Sitting Duck Advertising, to better reflect its innovative approach to media campaigns.

SentiAR, Inc. is a digital health company based in St. Louis, Missouri, specializing in 3D augmented reality solutions for interventional medical procedures. Founded in 2017 as a spin-off from Washington University, SentiAR has developed a platform that offers real-time holographic visualization of patients' anatomical structures and catheter locations. This technology integrates data from CT, MRI, and real-time mapping systems to create a controllable 3D holographic interface. The platform aims to enhance the delivery of care by allowing clinicians to visualize complex cardiac anatomy directly over the patient, thereby improving the treatment of cardiac arrhythmias during catheterization procedures. SentiAR is in the process of preparing its platform for submission to the FDA.

Textel CX Inc., established in 2014 and headquartered in Saint Louis, Missouri, specializes in developing a cloud-based texting platform for contact centers and businesses. Its primary product, Textel, enables these entities to engage with customers via text, enhancing customer experience and increasing engagement. Key features include landline texting, API integrations, and a text-to-find service, catering to industries such as car dealerships, insurance, healthcare, and retail. Textel serves nearly 800 customers across North America, facilitating inbound/outbound SMS and MMS texts, and integrating with leading systems of record.

Healthy Bytes, Inc. develops a software platform that facilitates personalized nutritional counseling, connecting physicians, employers, and patients. Founded in 2014 and headquartered in Saint Louis, Missouri, with an additional office in New York, the company employs registered dietitians who provide consultations to employees seeking medical care for conditions such as obesity, diabetes, high blood pressure, and cardiovascular diseases. The platform enables users to book private consultations and allows dietitians to monitor their clients' eating habits. By leveraging existing medical benefits, employees can access nutritional counseling without incurring additional costs, promoting healthier lifestyles through expert dietary guidance.

Geneoscopy, LLC, based in Saint Louis, Missouri, specializes in developing non-invasive diagnostic tests aimed at preventing, detecting, and guiding treatment for gastrointestinal diseases, particularly colorectal cancer. Founded in 2015, the company utilizes a proprietary platform that extracts stool-derived eukaryotic RNA (seRNA) to create a multi-target RNA biomarker panel. This innovative approach allows for the identification of colorectal cancer by capturing the effects of DNA mutations associated with the disease. Geneoscopy's technology not only enhances screening compliance but also facilitates the early detection of colorectal neoplasms, ultimately aiming to reduce morbidity and mortality linked to colorectal cancer. The company is also exploring additional applications of its technology for related gastrointestinal conditions.

Balto Software Inc. is a developer of sales software that leverages artificial intelligence and real-time conversation analytics to enhance the performance of sales representatives during phone calls. Founded in 2017 and based in Saint Louis, Missouri, Balto's platform offers agents live guidance by alerting them to mistakes and providing suggestions tailored to specific products, phrases, and industry terminology. The software monitors conversations for compliance and quality, allowing representatives to self-correct in real time, while also equipping managers with tools to oversee key behaviors. Balto's solutions support various functions, including sales leadership, customer service, and compliance, and have guided over 150 million calls, resulting in substantial revenue increases and high customer ratings. The company is trusted by numerous contact centers, helping to prevent missed sales opportunities and improve customer experiences.

Clever Real Estate is a company that specializes in the fields of commercial real estate and online marketplaces. It offers a software platform that guides its users through the process of interviewing real estate agents to find the right one for them. The company was founded in 2017 and is headquartered in St Louis, Missouri.

Well Principled Corp. is an artificial intelligence management consulting firm based in St. Louis, Missouri, founded in 2018. The company focuses on assisting chief marketing officers and chief supply chain officers by predicting customer buying behavior and optimizing marketing and supply chain processes for retail and consumer packaged goods brands. Its AI-driven software leverages data to deliver actionable insights grounded in academic business theories. By analyzing key factors such as customer retention, pricing, and product development, Well Principled provides businesses with strategic plans that enhance operational efficiency without the need for extensive analyst teams or traditional management consultants. This innovative approach enables brands to improve their growth and streamline operations in various areas, including retail assortments and advertising expenditures.

Arch Oncology, Inc. is an immuno-oncology company focused on discovering and developing antibody therapeutics for the treatment of solid tumors and hematologic cancers. Established in 2006 and headquartered in Brisbane, California, with a research laboratory in St. Louis, Missouri, the company specializes in anti-CD47 antibodies that represent a novel class of checkpoint inhibitors. These second-generation antibodies are designed to engage both the adaptive and innate immune systems, effectively targeting and killing tumor cells. By harnessing the body's immune response, Arch Oncology aims to provide new treatment options for patients battling cancer.

Aggio, LLC is an information technology company based in Saint Louis, Missouri, with an additional location in Madison, New Jersey. Founded in 2016, Aggio specializes in cloud-based sales applications tailored for the agriculture industry. The company's platform offers marketing and sales analytics that assist clients in making data-driven decisions through data harmonization and visualization. Aggio's software enables businesses to gain a comprehensive view of the market by integrating multiple data sources, facilitating effective engagement with customers and channel partners across both online and offline channels. This approach allows users to visualize and track key performance indicators, promoting faster decision-making processes.

Clever Real Estate is a company that specializes in the fields of commercial real estate and online marketplaces. It offers a software platform that guides its users through the process of interviewing real estate agents to find the right one for them. The company was founded in 2017 and is headquartered in St Louis, Missouri.

CoverCress Inc. is a biotechnology company based in St. Louis, Missouri, focused on developing and commercializing field pennycress as an oilseed crop. Founded in 2013, the company aims to produce oil for industrial and renewable fuels, as well as meal for nutritious livestock feed. CoverCress specializes in crop breeding services that enhance soil cover during corn harvest and soybean planting, allowing farmers to maximize yields through sustainable agricultural practices. The company is dedicated to utilizing low-input methods to create a feedstock for low carbon intensity biofuels, contributing to more efficient and environmentally friendly agricultural solutions.

SimpleRose Inc. is a technology company based in Saint Louis, Missouri, that specializes in developing a prescriptive analytics platform aimed at enhancing decision-making processes in complex environments. Founded in 2018, the company's solutions focus on optimizing operations through applications such as scheduling, production planning, and portfolio optimization. By leveraging algorithmic innovations for improved numerical accuracy and speed, SimpleRose enables organizations to tackle intricate operational challenges and make informed decisions in real-time.

iSite Media, LLC specializes in advertising and marketing services utilizing digital display technology. Founded in 2015 and based in St. Louis, Missouri, the company focuses on delivering brand promotion through digital display networks located in restrooms. This unique placement allows for high visibility and relevance, enhancing consumer recall and engagement. iSite Media bridges the gap between content and consumers, ensuring that advertisements reach the appropriate audience in various environments outside the home. In 2017, the company rebranded from its former name, Sitting Duck Advertising, to better reflect its innovative approach to media campaigns.

FinLocker, LLC is a financial technology company founded in 2014 and based in St. Louis, Missouri. It develops a consumer-enabled financial data platform that facilitates the loan process for mortgages and other financial products. The platform serves both businesses and consumers by streamlining loan transactions and enhancing the overall financial experience. For businesses, FinLocker provides tools that cut costs, reduce fraud, and mitigate risks while improving customer satisfaction and operational efficiency. For consumers, the platform simplifies the loan application process, minimizes paperwork, and enables better management of personal finances. Using consumer consent, FinLocker captures essential borrower data and employs intelligent analytics to offer tailored loan product recommendations based on individual financial profiles.

SentiAR, Inc. is a digital health company based in St. Louis, Missouri, specializing in 3D augmented reality solutions for interventional medical procedures. Founded in 2017 as a spin-off from Washington University, SentiAR has developed a platform that offers real-time holographic visualization of patients' anatomical structures and catheter locations. This technology integrates data from CT, MRI, and real-time mapping systems to create a controllable 3D holographic interface. The platform aims to enhance the delivery of care by allowing clinicians to visualize complex cardiac anatomy directly over the patient, thereby improving the treatment of cardiac arrhythmias during catheterization procedures. SentiAR is in the process of preparing its platform for submission to the FDA.

Aptimmune is a biotechnology company based in St. Louis, Missouri, founded in 2010. The company specializes in developing mucosal vaccines for swine to combat viral diseases, specifically targeting Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and influenza A virus. Aptimmune employs innovative technologies, including its proprietary pig alveolar macrophage cell line ZMAC, to create effective nasal delivery vaccines. These advancements aim to provide animal breeders with lasting immune responses and enhanced disease protection, contributing to the overall health and productivity of swine populations.

SentiAR, Inc. is a digital health company based in St. Louis, Missouri, specializing in 3D augmented reality solutions for interventional medical procedures. Founded in 2017 as a spin-off from Washington University, SentiAR has developed a platform that offers real-time holographic visualization of patients' anatomical structures and catheter locations. This technology integrates data from CT, MRI, and real-time mapping systems to create a controllable 3D holographic interface. The platform aims to enhance the delivery of care by allowing clinicians to visualize complex cardiac anatomy directly over the patient, thereby improving the treatment of cardiac arrhythmias during catheterization procedures. SentiAR is in the process of preparing its platform for submission to the FDA.

Noonlight, Inc. is a company that specializes in personal safety through its mobile application, which connects various Internet of Things (IoT) devices to enhance user protection. Founded in 2013 and headquartered in Saint Louis, Missouri, Noonlight's platform provides 24/7 professional monitoring and data-driven emergency response capabilities. The application enables users to create accounts and connect multiple devices, allowing for precise location detection in emergencies. In critical situations, it can alert authorities without necessitating a 911 call or verbal communication. Noonlight's technology is operational across the United States, making it a versatile tool for enhancing personal safety and comfort.

CoverCress Inc. is a biotechnology company based in St. Louis, Missouri, focused on developing and commercializing field pennycress as an oilseed crop. Founded in 2013, the company aims to produce oil for industrial and renewable fuels, as well as meal for nutritious livestock feed. CoverCress specializes in crop breeding services that enhance soil cover during corn harvest and soybean planting, allowing farmers to maximize yields through sustainable agricultural practices. The company is dedicated to utilizing low-input methods to create a feedstock for low carbon intensity biofuels, contributing to more efficient and environmentally friendly agricultural solutions.

BenchmarkONE develops sales and marketing automation software tailored for small and mid-sized businesses. The company offers an integrated platform that includes customer relationship management (CRM) tools and sales automation features, allowing users to monitor contacts' activities, track deals, manage communications, and segment their audience. Additionally, BenchmarkONE provides email marketing capabilities with a user-friendly drag-and-drop email builder and marketing automation tools designed to engage visitors, prioritize leads, and optimize campaign investments. Originally known as Hatchbuck, Inc., the company rebranded to BenchmarkONE in June 2020 and has been operational since 2010, with its headquarters in St. Louis, Missouri. As of September 2019, BenchmarkONE functions as a subsidiary of Benchmark Internet Group, LLC.

Euclises Pharmaceuticals, Inc. is engaged in the research, development, and commercialization of innovative medicines targeting inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company focuses on creating novel pain and cancer medications that promise enhanced safety profiles compared to current therapies. The firm is built on pioneering inventions by Dr. John Talley, a renowned medicinal chemist known for developing Celebrex among other approved drugs. Euclises aims to introduce new compounds that provide improved efficacy and safety, positioning itself as a leader in the pharmaceutical industry. The company operates from the BioGenerator Accelerator Labs, where it continues to advance its research initiatives.

FinLocker, LLC is a financial technology company founded in 2014 and based in St. Louis, Missouri. It develops a consumer-enabled financial data platform that facilitates the loan process for mortgages and other financial products. The platform serves both businesses and consumers by streamlining loan transactions and enhancing the overall financial experience. For businesses, FinLocker provides tools that cut costs, reduce fraud, and mitigate risks while improving customer satisfaction and operational efficiency. For consumers, the platform simplifies the loan application process, minimizes paperwork, and enables better management of personal finances. Using consumer consent, FinLocker captures essential borrower data and employs intelligent analytics to offer tailored loan product recommendations based on individual financial profiles.

Arch Oncology, Inc. is an immuno-oncology company focused on discovering and developing antibody therapeutics for the treatment of solid tumors and hematologic cancers. Established in 2006 and headquartered in Brisbane, California, with a research laboratory in St. Louis, Missouri, the company specializes in anti-CD47 antibodies that represent a novel class of checkpoint inhibitors. These second-generation antibodies are designed to engage both the adaptive and innate immune systems, effectively targeting and killing tumor cells. By harnessing the body's immune response, Arch Oncology aims to provide new treatment options for patients battling cancer.

BlueStrata EHR is a St. Louis-based company that specializes in developing a cloud-based electronic health records (EHR) software platform tailored for long-term care and resident care facilities. The platform integrates clinical, financial, and point-of-care services, facilitating seamless data sharing across medical records and billing systems. BlueStrata EHR's intuitive design incorporates easily accessible touch screen kiosks, allowing caregivers to capture accurate resident care information from any location. Since August 1, 2018, the company has operated as a subsidiary of Mediware Information Systems, Inc.

Euclises Pharmaceuticals, Inc. is engaged in the research, development, and commercialization of innovative medicines targeting inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company focuses on creating novel pain and cancer medications that promise enhanced safety profiles compared to current therapies. The firm is built on pioneering inventions by Dr. John Talley, a renowned medicinal chemist known for developing Celebrex among other approved drugs. Euclises aims to introduce new compounds that provide improved efficacy and safety, positioning itself as a leader in the pharmaceutical industry. The company operates from the BioGenerator Accelerator Labs, where it continues to advance its research initiatives.

Noonlight, Inc. is a company that specializes in personal safety through its mobile application, which connects various Internet of Things (IoT) devices to enhance user protection. Founded in 2013 and headquartered in Saint Louis, Missouri, Noonlight's platform provides 24/7 professional monitoring and data-driven emergency response capabilities. The application enables users to create accounts and connect multiple devices, allowing for precise location detection in emergencies. In critical situations, it can alert authorities without necessitating a 911 call or verbal communication. Noonlight's technology is operational across the United States, making it a versatile tool for enhancing personal safety and comfort.

Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, founded in 2008. The company specializes in developing a rapid and label-free biological assay platform that measures clinical and point-of-care samples. This innovative platform employs diagnostic arrayed imaging reflectometry (AIR) to enable the simultaneous detection of hundreds of analytes from a single drop of fluid, allowing healthcare professionals to conduct sophisticated tests with high sensitivity and specificity. By significantly reducing the time required for testing, Adarza BioSystems aims to enhance diagnostic capabilities in various healthcare settings.

FinLocker, LLC is a financial technology company founded in 2014 and based in St. Louis, Missouri. It develops a consumer-enabled financial data platform that facilitates the loan process for mortgages and other financial products. The platform serves both businesses and consumers by streamlining loan transactions and enhancing the overall financial experience. For businesses, FinLocker provides tools that cut costs, reduce fraud, and mitigate risks while improving customer satisfaction and operational efficiency. For consumers, the platform simplifies the loan application process, minimizes paperwork, and enables better management of personal finances. Using consumer consent, FinLocker captures essential borrower data and employs intelligent analytics to offer tailored loan product recommendations based on individual financial profiles.

Label Insight, Inc. is a technology company that specializes in a cloud-based product data engine designed to help brands and retailers effectively manage their product information. Founded in 2004 and based in St. Louis, Missouri, with an additional office in Chicago and operations in Canada, the company collects and analyzes comprehensive data from product labels, including details on ingredients, allergens, nutrients, marketing claims, and certifications. This data is utilized by consumer packaged goods (CPG) brands, retailers, and other entities in the food industry to compare and analyze products across various categories such as food and beverage, apparel, personal care, and electronics. By transforming basic product data into insightful attributes, Label Insight enables its partners to unlock new growth opportunities and enhance consumer decision-making.

Euphrates Vascular is a medical technology company based in St. Louis, Missouri, that focuses on innovative solutions for the treatment of stroke, heart disease, and other conditions. The company has developed a proprietary magnetically-enhanced diffusion (MED) system that utilizes magnet-based technology to dissolve blood clots more rapidly than existing treatment options. This system aims to improve the efficacy of FDA-approved clot-busting medications, potentially reducing mortality rates associated with stroke and cardiovascular diseases. In addition to the MED system, Euphrates Vascular offers MED MicroBeads, which are designed to deliver therapeutic agents directly to clots during thrombolysis therapy, and a touch screen-operated MED Workstation. Founded by physicists with extensive experience in medical technology, the company continues to advance its pioneering approaches in the healthcare sector, attracting interest from investors and media alike.

Label Insight, Inc. is a technology company that specializes in a cloud-based product data engine designed to help brands and retailers effectively manage their product information. Founded in 2004 and based in St. Louis, Missouri, with an additional office in Chicago and operations in Canada, the company collects and analyzes comprehensive data from product labels, including details on ingredients, allergens, nutrients, marketing claims, and certifications. This data is utilized by consumer packaged goods (CPG) brands, retailers, and other entities in the food industry to compare and analyze products across various categories such as food and beverage, apparel, personal care, and electronics. By transforming basic product data into insightful attributes, Label Insight enables its partners to unlock new growth opportunities and enhance consumer decision-making.

Euclises Pharmaceuticals, Inc. is engaged in the research, development, and commercialization of innovative medicines targeting inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company focuses on creating novel pain and cancer medications that promise enhanced safety profiles compared to current therapies. The firm is built on pioneering inventions by Dr. John Talley, a renowned medicinal chemist known for developing Celebrex among other approved drugs. Euclises aims to introduce new compounds that provide improved efficacy and safety, positioning itself as a leader in the pharmaceutical industry. The company operates from the BioGenerator Accelerator Labs, where it continues to advance its research initiatives.

BenchmarkONE develops sales and marketing automation software tailored for small and mid-sized businesses. The company offers an integrated platform that includes customer relationship management (CRM) tools and sales automation features, allowing users to monitor contacts' activities, track deals, manage communications, and segment their audience. Additionally, BenchmarkONE provides email marketing capabilities with a user-friendly drag-and-drop email builder and marketing automation tools designed to engage visitors, prioritize leads, and optimize campaign investments. Originally known as Hatchbuck, Inc., the company rebranded to BenchmarkONE in June 2020 and has been operational since 2010, with its headquarters in St. Louis, Missouri. As of September 2019, BenchmarkONE functions as a subsidiary of Benchmark Internet Group, LLC.

Label Insight, Inc. is a technology company that specializes in a cloud-based product data engine designed to help brands and retailers effectively manage their product information. Founded in 2004 and based in St. Louis, Missouri, with an additional office in Chicago and operations in Canada, the company collects and analyzes comprehensive data from product labels, including details on ingredients, allergens, nutrients, marketing claims, and certifications. This data is utilized by consumer packaged goods (CPG) brands, retailers, and other entities in the food industry to compare and analyze products across various categories such as food and beverage, apparel, personal care, and electronics. By transforming basic product data into insightful attributes, Label Insight enables its partners to unlock new growth opportunities and enhance consumer decision-making.

BlueStrata EHR is a St. Louis-based company that specializes in developing a cloud-based electronic health records (EHR) software platform tailored for long-term care and resident care facilities. The platform integrates clinical, financial, and point-of-care services, facilitating seamless data sharing across medical records and billing systems. BlueStrata EHR's intuitive design incorporates easily accessible touch screen kiosks, allowing caregivers to capture accurate resident care information from any location. Since August 1, 2018, the company has operated as a subsidiary of Mediware Information Systems, Inc.

Arch Oncology, Inc. is an immuno-oncology company focused on discovering and developing antibody therapeutics for the treatment of solid tumors and hematologic cancers. Established in 2006 and headquartered in Brisbane, California, with a research laboratory in St. Louis, Missouri, the company specializes in anti-CD47 antibodies that represent a novel class of checkpoint inhibitors. These second-generation antibodies are designed to engage both the adaptive and innate immune systems, effectively targeting and killing tumor cells. By harnessing the body's immune response, Arch Oncology aims to provide new treatment options for patients battling cancer.

Tunespeak, LLC operates a musician-to-fan loyalty platform that rewards users for engaging with music and related content. Founded in 2011 and based in St. Louis, Missouri, the platform allows users to earn points by listening to music, watching videos, viewing photos, and sharing content with friends. Users can accumulate points not only for their own activity but also for enabling their friends to participate in contests or raffles for every song, picture, and video shared. Through this unique engagement model, Tunespeak aims to enhance the connection between musicians and their fans while offering incentives such as tickets, experiences, and merchandise.

CoverCress Inc. is a biotechnology company based in St. Louis, Missouri, focused on developing and commercializing field pennycress as an oilseed crop. Founded in 2013, the company aims to produce oil for industrial and renewable fuels, as well as meal for nutritious livestock feed. CoverCress specializes in crop breeding services that enhance soil cover during corn harvest and soybean planting, allowing farmers to maximize yields through sustainable agricultural practices. The company is dedicated to utilizing low-input methods to create a feedstock for low carbon intensity biofuels, contributing to more efficient and environmentally friendly agricultural solutions.

BenchmarkONE develops sales and marketing automation software tailored for small and mid-sized businesses. The company offers an integrated platform that includes customer relationship management (CRM) tools and sales automation features, allowing users to monitor contacts' activities, track deals, manage communications, and segment their audience. Additionally, BenchmarkONE provides email marketing capabilities with a user-friendly drag-and-drop email builder and marketing automation tools designed to engage visitors, prioritize leads, and optimize campaign investments. Originally known as Hatchbuck, Inc., the company rebranded to BenchmarkONE in June 2020 and has been operational since 2010, with its headquarters in St. Louis, Missouri. As of September 2019, BenchmarkONE functions as a subsidiary of Benchmark Internet Group, LLC.

Euclises Pharmaceuticals, Inc. is engaged in the research, development, and commercialization of innovative medicines targeting inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company focuses on creating novel pain and cancer medications that promise enhanced safety profiles compared to current therapies. The firm is built on pioneering inventions by Dr. John Talley, a renowned medicinal chemist known for developing Celebrex among other approved drugs. Euclises aims to introduce new compounds that provide improved efficacy and safety, positioning itself as a leader in the pharmaceutical industry. The company operates from the BioGenerator Accelerator Labs, where it continues to advance its research initiatives.

ImmunoPhotonics, Inc. is a biotechnology company focused on developing innovative immunotherapy treatments for cancer, specifically targeting metastatic solid tumors. Founded in 2008 and located in Columbia, Missouri, the company has created a proprietary drug product designed to function as a minimally invasive therapeutic cancer vaccine. This product is administered through intratumoral injection following tumor ablation, leveraging tumor-associated neoantigens to stimulate a systemic anti-tumor immune response. By transforming the process of tumor ablation into a therapeutic approach, ImmunoPhotonics aims to enhance treatment options for patients with late-stage metastatic cancers. The company has also established a strategic partnership with Veterinary Cancer Therapeutics, LLC to further its mission in cancer treatment.

Label Insight, Inc. is a technology company that specializes in a cloud-based product data engine designed to help brands and retailers effectively manage their product information. Founded in 2004 and based in St. Louis, Missouri, with an additional office in Chicago and operations in Canada, the company collects and analyzes comprehensive data from product labels, including details on ingredients, allergens, nutrients, marketing claims, and certifications. This data is utilized by consumer packaged goods (CPG) brands, retailers, and other entities in the food industry to compare and analyze products across various categories such as food and beverage, apparel, personal care, and electronics. By transforming basic product data into insightful attributes, Label Insight enables its partners to unlock new growth opportunities and enhance consumer decision-making.

Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, founded in 2008. The company specializes in developing a rapid and label-free biological assay platform that measures clinical and point-of-care samples. This innovative platform employs diagnostic arrayed imaging reflectometry (AIR) to enable the simultaneous detection of hundreds of analytes from a single drop of fluid, allowing healthcare professionals to conduct sophisticated tests with high sensitivity and specificity. By significantly reducing the time required for testing, Adarza BioSystems aims to enhance diagnostic capabilities in various healthcare settings.

Euclises Pharmaceuticals, Inc. is engaged in the research, development, and commercialization of innovative medicines targeting inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company focuses on creating novel pain and cancer medications that promise enhanced safety profiles compared to current therapies. The firm is built on pioneering inventions by Dr. John Talley, a renowned medicinal chemist known for developing Celebrex among other approved drugs. Euclises aims to introduce new compounds that provide improved efficacy and safety, positioning itself as a leader in the pharmaceutical industry. The company operates from the BioGenerator Accelerator Labs, where it continues to advance its research initiatives.

ImmunoPhotonics, Inc. is a biotechnology company focused on developing innovative immunotherapy treatments for cancer, specifically targeting metastatic solid tumors. Founded in 2008 and located in Columbia, Missouri, the company has created a proprietary drug product designed to function as a minimally invasive therapeutic cancer vaccine. This product is administered through intratumoral injection following tumor ablation, leveraging tumor-associated neoantigens to stimulate a systemic anti-tumor immune response. By transforming the process of tumor ablation into a therapeutic approach, ImmunoPhotonics aims to enhance treatment options for patients with late-stage metastatic cancers. The company has also established a strategic partnership with Veterinary Cancer Therapeutics, LLC to further its mission in cancer treatment.

BenchmarkONE develops sales and marketing automation software tailored for small and mid-sized businesses. The company offers an integrated platform that includes customer relationship management (CRM) tools and sales automation features, allowing users to monitor contacts' activities, track deals, manage communications, and segment their audience. Additionally, BenchmarkONE provides email marketing capabilities with a user-friendly drag-and-drop email builder and marketing automation tools designed to engage visitors, prioritize leads, and optimize campaign investments. Originally known as Hatchbuck, Inc., the company rebranded to BenchmarkONE in June 2020 and has been operational since 2010, with its headquarters in St. Louis, Missouri. As of September 2019, BenchmarkONE functions as a subsidiary of Benchmark Internet Group, LLC.

Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, founded in 2008. The company specializes in developing a rapid and label-free biological assay platform that measures clinical and point-of-care samples. This innovative platform employs diagnostic arrayed imaging reflectometry (AIR) to enable the simultaneous detection of hundreds of analytes from a single drop of fluid, allowing healthcare professionals to conduct sophisticated tests with high sensitivity and specificity. By significantly reducing the time required for testing, Adarza BioSystems aims to enhance diagnostic capabilities in various healthcare settings.

Tunespeak, LLC operates a musician-to-fan loyalty platform that rewards users for engaging with music and related content. Founded in 2011 and based in St. Louis, Missouri, the platform allows users to earn points by listening to music, watching videos, viewing photos, and sharing content with friends. Users can accumulate points not only for their own activity but also for enabling their friends to participate in contests or raffles for every song, picture, and video shared. Through this unique engagement model, Tunespeak aims to enhance the connection between musicians and their fans while offering incentives such as tickets, experiences, and merchandise.

Wealth Access, Inc. is a financial technology company that provides personal financial management tools tailored for registered investment advisors and their high net worth clients. Founded in 2011 and headquartered in Nashville, Tennessee, the company offers a proprietary cloud-based platform that facilitates wealth reporting and investment monitoring. This platform features an intuitive interface and advanced aggregation capabilities, managing data from over 20,000 financial institutions. By rendering complex global portfolios into a clear, real-time digital dashboard, Wealth Access enables financial advisors and their clients to navigate the wealth management landscape effectively. The company also has additional locations in St. Louis, Missouri; Dallas, Texas; New York, New York; and Tampa, Florida, serving the financial services sector.

Euphrates Vascular is a medical technology company based in St. Louis, Missouri, that focuses on innovative solutions for the treatment of stroke, heart disease, and other conditions. The company has developed a proprietary magnetically-enhanced diffusion (MED) system that utilizes magnet-based technology to dissolve blood clots more rapidly than existing treatment options. This system aims to improve the efficacy of FDA-approved clot-busting medications, potentially reducing mortality rates associated with stroke and cardiovascular diseases. In addition to the MED system, Euphrates Vascular offers MED MicroBeads, which are designed to deliver therapeutic agents directly to clots during thrombolysis therapy, and a touch screen-operated MED Workstation. Founded by physicists with extensive experience in medical technology, the company continues to advance its pioneering approaches in the healthcare sector, attracting interest from investors and media alike.

Mobius Therapeutics, LLC is a developer of sterile injectable pharmaceutical products focused on ophthalmic applications in the United States. Founded in 2006 and based in St. Louis, Missouri, the company offers Mitosol, a kit that provides a safe method for reconstituting and transferring mitomycin, an antifibrotic agent used in glaucoma, refractive, and corneal surgeries. Additionally, Mobius Therapeutics produces Amphadase, a hyaluronidase injection. The company serves ophthalmologists and their patients by providing products that enhance surgical outcomes and patient care. Its offerings are available for purchase online, and the company is actively pursuing regulatory approval for its products, with further developments in the pipeline.

Tunespeak, LLC operates a musician-to-fan loyalty platform that rewards users for engaging with music and related content. Founded in 2011 and based in St. Louis, Missouri, the platform allows users to earn points by listening to music, watching videos, viewing photos, and sharing content with friends. Users can accumulate points not only for their own activity but also for enabling their friends to participate in contests or raffles for every song, picture, and video shared. Through this unique engagement model, Tunespeak aims to enhance the connection between musicians and their fans while offering incentives such as tickets, experiences, and merchandise.

Label Insight, Inc. is a technology company that specializes in a cloud-based product data engine designed to help brands and retailers effectively manage their product information. Founded in 2004 and based in St. Louis, Missouri, with an additional office in Chicago and operations in Canada, the company collects and analyzes comprehensive data from product labels, including details on ingredients, allergens, nutrients, marketing claims, and certifications. This data is utilized by consumer packaged goods (CPG) brands, retailers, and other entities in the food industry to compare and analyze products across various categories such as food and beverage, apparel, personal care, and electronics. By transforming basic product data into insightful attributes, Label Insight enables its partners to unlock new growth opportunities and enhance consumer decision-making.

BenchmarkONE develops sales and marketing automation software tailored for small and mid-sized businesses. The company offers an integrated platform that includes customer relationship management (CRM) tools and sales automation features, allowing users to monitor contacts' activities, track deals, manage communications, and segment their audience. Additionally, BenchmarkONE provides email marketing capabilities with a user-friendly drag-and-drop email builder and marketing automation tools designed to engage visitors, prioritize leads, and optimize campaign investments. Originally known as Hatchbuck, Inc., the company rebranded to BenchmarkONE in June 2020 and has been operational since 2010, with its headquarters in St. Louis, Missouri. As of September 2019, BenchmarkONE functions as a subsidiary of Benchmark Internet Group, LLC.

Euphrates Vascular is a medical technology company based in St. Louis, Missouri, that focuses on innovative solutions for the treatment of stroke, heart disease, and other conditions. The company has developed a proprietary magnetically-enhanced diffusion (MED) system that utilizes magnet-based technology to dissolve blood clots more rapidly than existing treatment options. This system aims to improve the efficacy of FDA-approved clot-busting medications, potentially reducing mortality rates associated with stroke and cardiovascular diseases. In addition to the MED system, Euphrates Vascular offers MED MicroBeads, which are designed to deliver therapeutic agents directly to clots during thrombolysis therapy, and a touch screen-operated MED Workstation. Founded by physicists with extensive experience in medical technology, the company continues to advance its pioneering approaches in the healthcare sector, attracting interest from investors and media alike.